Cormorant Asset Management Holdings Inc


Top 10 CORMORANT ASSET MANAGEMENT Positions in Q3 2015
We can only speculate about the reasons for the dumping but we believe it has to do with either value, momentum or a better place for Cormorant Asset Management Llc’s capital. The fund also decreased its postitons in Minerva Neurosciences Inc (NERV.

Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs - PR Newswire (press release)
Replimune Raises $55M in Series B Funding FinSMEs (blog.

Cormorant Asset Management Doesn’t Think Corbus Pharmaceuticals Holdings Inc. (CRBP) Is Done Soaring Just Yet
In a new 13G filing with the SEC, Bihua Chen‘s Cormorant Asset Management reported ... Among the investors contained within Insider Monkey’s database, seven reported holding long positions in Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) as.

Term Sheet — Thursday, August 17 - Fortune
CROWDFUNDING: The JOBS Act, with its crowdfunding provision, was supposed to be kick off a revolution. Now anyone could invest in high-risk startup equity. It was supposed to disrupt the entire business of venture capital. Equity for all! And then it.

Cormorant Asset Management LLC Holding in Eagle Pharmaceuticals INC (EGRX) Has Decreased by $3.63 Million as Share Value Rose
Cormorant Asset Management Llc decreased its stake in Eagle Pharmaceuticals Inc (EGRX) by 10.09% based on its latest 2016Q4 regulatory filing with the SEC. Cormorant Asset Management Llc sold 45,995 shares as the company’s stock rose 7.49% with the market.

Cormorant Asset Management Has Cut Agenus (AGEN) Position By $628424; Horizon Pharma Plc Ord Ireland (HZNP ... -
Cormorant Asset Management Llc decreased Agenus Inc (AGEN) stake by 9.96% reported in 2016Q4 SEC filing. ... It is without change, as 10 investors sold AGEN shares while 29 reduced holdings . only 22 funds opened positions while 32 raised stakes.

Cormorant Asset Management Decreased Recro Pharma (REPH) Stake By $529912; Allergan plc Ordinary Shares ... -
Among 22 analysts covering Allergan Inc . (NYSE:AGN), 16 have Buy rating, 0 Sell and 6 Hold. Therefore 73% are positive. Allergan Inc . had 68 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday.

Eagle Asset Management Inc. Sells 39,471 Shares of Zimmer Biomet Holdings, Inc. (ZBH)
Eagle Asset Management Inc. reduced its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 10.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 349,931 shares of the.

Commerzbank Aktiengesellschaft Has Upped Anadarko Pete (APC) Stake By $1.84 Million; Cormorant Asset ... - MoneyMakingArticles
Anadarko Petroleum Corporation - APC - Stock Price Today - Zacks Zacks Investment Research.

Cormorant Asset Management, LLC notifies 5.81% shareholding in TiGenix
Chain of controlled undertakings through which the holdings are effectively held: Cormorant Asset Management, LLC is not a controlled entity. Cormorant Asset Management, LLC has received the discretionary power to exercise the voting rights of 11,756,894.

Aveo Pharmaceuticals Incorporated (NASDAQ:AVEO)'s Trend Unknown, Especially After Increased Shorts - WeeklyHub
A Reversal for Aveo Pharmaceuticals Incorporated (NASDAQ:AVEO) Is Not Near. The Stock Has Rise in Shorts Finance News Daily.

Cormorant Asset Management Has Trimmed Agenus (AGEN) Position; Philadelphia Financial Management Of San ... - Key Gazette
Cormorant Asset Management Llc decreased Agenus Inc (AGEN) stake by 9.96% reported in 2016Q4 SEC filing. Cormorant Asset Management Llc sold 157,106 shares as Agenus Inc (AGEN)'s stock declined 23.28%. The Cormorant Asset Management Llc&nbsp.

Cormorant Asset Management Has Trimmed Its Sangamo Biosciences (SGMO) Holding; Chimera Investment (CIM ... - High Point Observer
Cormorant Asset Management Llc decreased Sangamo Biosciences Inc (SGMO) stake by 53.65% reported in 2016Q4 SEC filing. Cormorant Asset Management Llc sold 752,331 shares as Sangamo Biosciences Inc (SGMO)'s stock rose 95.00.

As Portola Pharmaceuticals (PTLA) Shares Rose, Holder Cormorant Asset Management Decreased Holding; Bed Bath ... - San Times
Barry Investment Advisors Llc decreased its stake in Bed Bath & Beyond Inc (BBBY) by 43.31% based on its latest 2016Q4 regulatory filing with the SEC. Barry Investment Advisors Llc sold 46,486 shares as the company's stock declined 14.12% while stock&nbsp.

Cormorant Asset Management Has Decreased Omeros (OMER) Holding By $6.48 Million; Brown Advisory Has Raised Bank New York Mellon (BK) Holding
It improved, as 45 investors sold BK shares while 317 reduced holdings. 122 funds opened positions ... was maintained by Needham with “Buy”. Cormorant Asset Management Llc increased Fulgent Genetics Inc stake by 57,663 shares to 857,663 valued at.